Key Factors Influencing Tuberculosis and Diabetes Management

Latent tuberculosis infection (LTBI) develops in individuals who are unable to clear Mycobacterium tuberculosis initially, and its treatment aims to prevent progression to active TB. In low TB-burden countries, LTBI treatment is particularly recommended for high-risk groups, such as people living with HIV, close contacts of active TB patients, and patients with conditions like silicosis or awaiting organ transplants. However, targeting diabetics for LTBI screening may not offer significant benefits according to some studies.

Lower socioeconomic status increases exposure to TB, particularly in diabetics due to network dynamics. This is especially concerning in low- and middle-income countries (LMICs), where TB and diabetes care are typically managed separately. Financial challenges, including the high cost of diabetes medication and potential job loss due to TB, hinder effective diabetes self-management. Financial incentives and educational programs can encourage better diabetes care, although these efforts require further support, including culturally appropriate guidance and resources on alternative therapies.

Environmental factors, such as smoking and indoor air pollution from biomass, are linked to higher TB risk, as they impair airway defense mechanisms. High levels of ambient air pollution, particularly in developing countries, correlate with continued TB rates. Research suggests a connection between fine particles, traffic pollutants, and TB incidence, though the full extent of the relationship may be underestimated due to confounding factors like socioeconomic status.

Tuberculosis poses a significant occupational hazard for healthcare workers (HCWs), as shown by studies in Taiwan. HCWs have higher TB incidence rates than the general population, but their outcomes are typically better due to quicker diagnosis and treatment. This is attributed to the "healthy worker effect" and more efficient care pathways within healthcare settings.

Efforts to expand tuberculosis care in countries like India, China, and South Africa have yielded substantial health gains. Expanding access to care has proven to be both beneficial and cost-effective, particularly when compared to conventional treatment practices. These expanded services have also helped reduce the financial burden on patients, with some interventions resulting in societal cost savings.

However, scaling up TB services comes with significant cost implications, often requiring more than double the current funding levels. Policymakers must consider the effectiveness and efficiency of various approaches, as well as the need for substantial new funding to successfully implement expanded care. Despite the higher costs, the economic and health benefits, especially in terms of patient cost reductions, make service expansion a valuable endeavor.

Read more: https://tbreadingnotes.blogspot.com/

References:

1. Lee, M.R., Huang, Y.P., Kuo, Y.T., Luo, C.H., Shih, Y.J., Shu, C.C., Wang, J.Y., Ko, J.C., Yu, C.J. and Lin, H.H., 2017. Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis. Clinical Infectious Diseases, 64(6), pp.719-727.
2. Oliveira Hashiguchi, L., Cox, S.E., Edwards, T. et al. How can tuberculosis services better support patients with a diabetes co-morbidity? A mixed methods study in the Philippines. BMC Health Serv Res 23, 1027 (2023).
3. Lai, T.C., Chiang, C.Y., Wu, C.F., Yang, S.L., Liu, D.P., Chan, C.C. and Lin, H.H., 2016. Ambient air pollution and risk of tuberculosis: a cohort study. Occupational and environmental medicine, 73(1), pp.56-61.
4. Pan S-C, Chen Y-C, Wang J-Y, Sheng W-H, Lin H-H, Fang C-T, et al. (2015) Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan. PLoS ONE 10(12): e0145047.
5. Menzies, N.A., Gomez, G.B., Bozzani, F., Chatterjee, S., Foster, N., Baena, I.G., Laurence, Y.V., Qiang, S., Siroka, A., Sweeney, S. and Verguet, S., 2016. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet global health, 4(11), pp.e816-e826.

TBC 008